Vigene Biosciences was founded in 2012 by senior scientists with expertise in the fields of virology and gene therapy. At Vigene, we strive to be the leading supplier of gene delivery technologies with the mission to advance biomedical research and to make gene therapy affordable. We offer both research-grade and cGMP-grade AAV, lentivirus, and adenovirus-based products and custom services. Some of our product offerings include ready-to-ship genome wide human cDNA ORFs on adenoviral or lentiviral vectors, AAV shRNA constructs, pre-made control GFP viruses, AAV biosensors developed in partnership with Janelia Research Campus, AAV alpha-synuclein vectors developed in partnership with The Michael J Fox Foundation, and many others. For more information, visit our websites for research (www.vigenebio.com) or cGMP (www.vigenegmp.com) services. You can also follow us on twitter at @VigeneBio.
View Top Employees from Vigene Biosciences, A Charles River Company| Website | https://www.vigenebio.com |
| Revenue | $16 million |
| Funding | $1 million |
| Employees | 32 (32 on RocketReach) |
| Founded | 2012 |
| Address | 5 Research Ct, Rockville, Maryland 20850, US |
| Phone | (301) 251-6638 |
| Fax | (301) 251-6110 |
| Technologies |
JavaScript,
HTML,
Twitter
+40 more
(view full list)
|
| Category | Biotechnology, Mirna Cloning, Pharmaceuticals, Science and Engineering, Adenovirus production, Healthcare, Genetics, Gene delivery, Health Care, Custom Service, Medical, Adenoviral Vector |
| Web Rank | 2 Million |
| Keywords | vigene biosciences, sendai virus vector price, vigene, adenovirus vs lentivirus, pav ctnt, gene therapy manufacturing pdf, viral vector production and purification |
| Competitors | DSS Takara Bio India Pvt Ltd, Molecular Medicine BioServices, Mycenax Biotech Inc., ProBioGen AG, SIRION BIOTECH GmbH |
| SIC | 87, 873 |
| NAICS | 54, 54171, 5417, 541, 541714 |
Looking for a particular Vigene Biosciences, A Charles River Company employee's phone or email?
Vigene Biosciences, A Charles River Company Questions
The Vigene Biosciences, A Charles River Company annual revenue was $16 million in 2023.
Chris DeMello is the Vice President of GMP Manufacturing of Vigene Biosciences, A Charles River Company.
32 people are employed at Vigene Biosciences, A Charles River Company.
Vigene Biosciences, A Charles River Company is based in Rockville, Maryland.
The NAICS codes for Vigene Biosciences, A Charles River Company are [54, 54171, 5417, 541, 541714].
The SIC codes for Vigene Biosciences, A Charles River Company are [87, 873].
Top Vigene Biosciences, A Charles River Company Employees
-
View
Chris DeMello
Vice President of GMP Manufacturing at Vigene Biosciences, A Charles River Company
College Station, TX, US35+ -
View
Patrick DePalma
Head of Gene Therapy Business Development at Vigene Biosciences, A Charles River Company
Webster, New York, United States32 -
ViewGuo-an Wang
Director, Plasmid Production at Vigene Biosciences, A Charles River Company
Rockville, Maryland, United States2 -
View
Cory Allgood
Manufacturing Associate III at Vigene Biosciences, A Charles River Company
Baltimore, Maryland, United States
Related Companies
